London: German vaccine-maker Curevac has said that its COVID-19 vaccine CVnCoV can remain stable for at least 3 months at 5 degrees Celsius. This would make it easier to distribute with normal refrigeration containers, unlike Pfizer’s vaccine which reportedly requires -70 degrees Celsius.
However, Curevac is not one of the frontrunners in the vaccine race. It hopes to start phase 3 trials by end of the this year. Frontrunners such as Moderna, Pfizer, AstraZeneca and Johnson & Johnson are ahead in the race with some ready to launch the vaccine in a couple of months.
Mumbai: Bollywood celebrities have often had funny, at times bizarre experiences, mostly involving hero-worshipping, demanding fans.…
Bhubaneswar: Police have arrested the owner of a Jatra (theatre) group for allegedly duping an…
Sanskriti Talwar Faridkot (Punjab): For the third consecutive year, Balwinder Singh of Mallan village in…
Bhubaneswar: Rain may play spoilsport in Christmas and New Year celebrations in Odisha as the…
New Delhi: Netflix showed the way, Amazon Prime Video is following in their footsteps. Come…
Hyderabad: Allu Arjun’s woes keep mounting. In a worrying development, protesters stormed Allu Arjun’s Jubilee…
This website uses cookies.